HK7397A - Injection solutions containing mesna - Google Patents

Injection solutions containing mesna Download PDF

Info

Publication number
HK7397A
HK7397A HK7397A HK7397A HK7397A HK 7397 A HK7397 A HK 7397A HK 7397 A HK7397 A HK 7397A HK 7397 A HK7397 A HK 7397A HK 7397 A HK7397 A HK 7397A
Authority
HK
Hong Kong
Prior art keywords
mesna
solution
injection solutions
solutions containing
value
Prior art date
Application number
HK7397A
Other languages
German (de)
English (en)
French (fr)
Inventor
Engel Prof Dr Juergen
Wolf-Heuss Dr Elisabeth
Deger Dr Wolfgang
Camuglia Giancarlo
Sauerbier Dieter
Original Assignee
Asta Medica Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Aktiengesellschaft filed Critical Asta Medica Aktiengesellschaft
Publication of HK7397A publication Critical patent/HK7397A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/105—Persulfides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Luminescent Compositions (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Peptides Or Proteins (AREA)
  • Filling Or Discharging Of Gas Storage Vessels (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
HK7397A 1992-10-08 1997-01-16 Injection solutions containing mesna HK7397A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4233842A DE4233842A1 (de) 1992-10-08 1992-10-08 Mesna Injektionslösungen

Publications (1)

Publication Number Publication Date
HK7397A true HK7397A (en) 1997-01-24

Family

ID=6469925

Family Applications (1)

Application Number Title Priority Date Filing Date
HK7397A HK7397A (en) 1992-10-08 1997-01-16 Injection solutions containing mesna

Country Status (28)

Country Link
US (2) US5728738A (cg-RX-API-DMAC7.html)
EP (1) EP0591710B1 (cg-RX-API-DMAC7.html)
JP (1) JP3636372B2 (cg-RX-API-DMAC7.html)
KR (1) KR100364466B1 (cg-RX-API-DMAC7.html)
CN (1) CN1071114C (cg-RX-API-DMAC7.html)
AT (1) ATE139693T1 (cg-RX-API-DMAC7.html)
AU (1) AU667129B2 (cg-RX-API-DMAC7.html)
BR (1) BR9304151A (cg-RX-API-DMAC7.html)
CA (1) CA2107961C (cg-RX-API-DMAC7.html)
CZ (1) CZ284584B6 (cg-RX-API-DMAC7.html)
DE (2) DE4233842A1 (cg-RX-API-DMAC7.html)
DK (1) DK0591710T3 (cg-RX-API-DMAC7.html)
EG (1) EG20308A (cg-RX-API-DMAC7.html)
ES (1) ES2089661T3 (cg-RX-API-DMAC7.html)
FI (1) FI111804B (cg-RX-API-DMAC7.html)
GR (1) GR3020669T3 (cg-RX-API-DMAC7.html)
HK (1) HK7397A (cg-RX-API-DMAC7.html)
HR (1) HRP931267B1 (cg-RX-API-DMAC7.html)
HU (1) HU217123B (cg-RX-API-DMAC7.html)
IL (1) IL107187A (cg-RX-API-DMAC7.html)
NO (1) NO303712B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ248873A (cg-RX-API-DMAC7.html)
RU (1) RU2105550C1 (cg-RX-API-DMAC7.html)
SI (1) SI9300525A (cg-RX-API-DMAC7.html)
SK (1) SK279609B6 (cg-RX-API-DMAC7.html)
TW (1) TW279131B (cg-RX-API-DMAC7.html)
UA (1) UA26134C2 (cg-RX-API-DMAC7.html)
ZA (1) ZA937458B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
IT1284973B1 (it) * 1996-10-11 1998-05-28 A R D O Associazione Ricerca E Uso del sodio 2-mercaptoetansolfonato (mesna) in chirurgia
US6031006A (en) * 1999-10-21 2000-02-29 Bionumerik Pharmaceuticals, Inc. Method of treating diabetic nephropathy
TW201036529A (en) 2009-03-25 2010-10-01 Askey Computer Corp A liquid crystal anti-freeze method and a liquid crystal module using the liquid crystal anti-freeze method
UA74097U (ru) * 2012-07-24 2012-10-10 Николай Иванович Гуменюк Способ изготовления средства для лечения туберкулеза
WO2014180902A1 (en) 2013-05-07 2014-11-13 Auxin Surgery Sa Device for chemically assisted dissection
CA3017403A1 (en) 2016-03-14 2017-09-21 Auxin Surgery Sa Device, method and formulation for chemically assisted dissection
BE1024110B1 (fr) * 2016-10-18 2017-11-16 Auxin Surgery Sa Dispositif, procédé et formulation pour dissection assistée de manière chimique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3111770A1 (de) * 1981-03-25 1982-10-07 Heyl Chemisch-pharmazeutische Fabrik GmbH & Co KG, 1000 Berlin Verwendung von dimercaptopropansulfonsaeure und dimercaptobernsteinsaeure zur herstellung von pharmazeutischen mitteln
IT1185551B (it) * 1985-04-15 1987-11-12 Schering Spa Composizioni farmaceutiche a base di acido mercaptoetansolfonico ad attivita' terapeutica,derivati salini organici dell'acido mercaptoetansolfonico utili per tali composizioni e relativo procedimento di preparazione
EP0334083B1 (de) * 1988-03-19 1991-07-24 ASTA Pharma Aktiengesellschaft Ifosfamid-Mesna-Lyophilisat und Verfahren zu dessen Herstellung

Also Published As

Publication number Publication date
CZ284584B6 (cs) 1999-01-13
HRP931267A2 (en) 1994-12-31
CN1071114C (zh) 2001-09-19
HUT65096A (en) 1994-04-28
ES2089661T3 (es) 1996-10-01
RU2105550C1 (ru) 1998-02-27
FI934410L (fi) 1994-04-09
ATE139693T1 (de) 1996-07-15
DK0591710T3 (da) 1996-09-30
FI934410A0 (fi) 1993-10-07
NO933590L (no) 1994-04-11
NZ248873A (en) 1995-10-26
ZA937458B (en) 1994-04-26
CZ209793A3 (en) 1994-04-13
HU217123B (hu) 1999-11-29
TW279131B (cg-RX-API-DMAC7.html) 1996-06-21
EG20308A (en) 1998-10-31
JPH06263629A (ja) 1994-09-20
IL107187A0 (en) 1994-01-25
CN1089137A (zh) 1994-07-13
SK107993A3 (en) 1994-05-11
HU9302837D0 (en) 1993-12-28
UA26134C2 (uk) 1999-06-07
GR3020669T3 (en) 1996-10-31
CA2107961A1 (en) 1994-04-09
EP0591710B1 (de) 1996-06-26
EP0591710A1 (de) 1994-04-13
NO933590D0 (no) 1993-10-07
JP3636372B2 (ja) 2005-04-06
HRP931267B1 (en) 1997-08-31
BR9304151A (pt) 1994-06-07
DE59303067D1 (de) 1996-08-01
AU667129B2 (en) 1996-03-07
SK279609B6 (sk) 1999-01-11
US5696172A (en) 1997-12-09
US5728738A (en) 1998-03-17
FI111804B (fi) 2003-09-30
CA2107961C (en) 2003-03-25
KR940008678A (ko) 1994-05-16
AU4888393A (en) 1994-04-21
KR100364466B1 (ko) 2003-01-29
IL107187A (en) 1999-03-12
NO303712B1 (no) 1998-08-24
DE4233842A1 (de) 1994-04-14
SI9300525A (en) 1994-06-30

Similar Documents

Publication Publication Date Title
SK285650B6 (sk) Vodné prípravky moxifloxacínu a chloridu sodného,spôsob ich výroby a kombinovaný preparát
CZ298581B6 (cs) Farmaceuticky stabilní prípravek oxaliplatiny k parenterální aplikaci
WO2001078732A1 (de) Lagerstabile infusionslösung des ciprofloxacins
HK7397A (en) Injection solutions containing mesna
US5662918A (en) Pharmaceutical agents containing diphosphonic acids and salts thereof
US4619935A (en) Stable oncolytic formulations
US11324692B2 (en) Method to prepare pharmaceutical compositions of suggamadex
JP3672342B2 (ja) ビスホスホン酸又はその誘導体を含有する注射液とその安定化方法、及び注射液アンプル
JP3744857B2 (ja) アルファ−２，４−ジスルホフェニル−Ｎ−ｔｅｒｔ−ブチルニトロンの新規な処方物
US5834520A (en) Container for injectable mesna solutions
MXPA03002770A (es) Infusion de ciprofloxacina con un contenido de acido reducido y estable al almacenamiento.
CA2615053C (en) Pharmaceutical formulations of endo-n-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1-methyl-1h-indazole-3-carboxamide hydrochloride
JP2021138649A (ja) スガマデクス含有の液体製剤及びその製造方法
CN110101657A (zh) 一种左氧氟沙星单剂量滴眼液及其制备方法
GB2125292A (en) Stable aqueous formulations of vinca alkaloids
US3121664A (en) Stable, hermetically sealed isotonic parenteral vehicles containing buffered warfarin sodium
EP1551464B1 (en) Use of paraben comprising compositions
DE3907079A1 (de) Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung
SI9300029A (en) Lecithin-containing solutions with levemopamil
WO2001078731A1 (de) Infusionslösungen des ciprofloxacins mit verbesserter lagerfähigkeit
EP3932391A1 (en) Method to prepare pharmaceutical compositions
HU204436B (en) Process for producing parenteral aqouos pharmaceutical composition containing tobramycin, apramycin or gentamycin

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20130912